Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 6 undervalued ...

P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Arvinas, Inc. (“Arvinas” or the ...

Pomerantz LLP is investigating claims on behalf of investors of Arvinas, Inc. ("Arvinas" or the "Company") . Such investors are advised to contact Danielle Peyton at [email protected] or ...

Fintel reports that on May 5, 2025, Truist Securities downgraded their outlook for Arvinas (NasdaqGS:ARVN) from Buy to Hold. Analyst Price Forecast Suggests 321.24% Upside As of April 24 ...

Ratings for Arvinas (NASDAQ:ARVN) were provided by 25 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below provides a snapshot of their recent ...

(MENAFN- GlobeNewsWire - Nasdaq) NEW YORK, May 05, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Arvinas, Inc. (“Arvinas” or the“Company ...

Pomerantz LLP is investigating claims on behalf of investors of Arvinas, Inc. (“Arvinas” or the “Company”) (NASDAQ: ARVN). Such investors are advised ...

The state of Connecticut “WARN” site that reports such layoffs indicates that 92 of the people to be laid off are state residents. CVS Health also made its recent report to the state, noting it is ...

Shares of Arvinas stock opened at $7.72 on Friday. The firm has a market capitalization of $563.49 million, a PE ratio of -2.79 and a beta of 2.21. The firm’s 50 day moving average is $9.66 and ...

Arvinas had a negative net margin of 75.51% and a negative return on equity of 33.75%. The business’s quarterly revenue was up 646.2% compared to the same quarter last year.